Sabby Management’s Ocera Therapeutics OCRX Stock Holding History
Bought
Maintained
Sold
Other funds holding OCRX
ECM
Sabby Management's OCRX Position: Q1 2017 in Review
Sabby Management sold out of Ocera Therapeutics (OCRX) in Q1 2017, closing a stake of 328,632 shares — an estimated $690K sold.
Sabby Management first reported a position in OCRX in Q4 2013 and held it in 12 quarters. The position peaked at $2.74M in Q4 2014. 26 funds tracked by Wall St. Rank hold OCRX as of Q1 2017.
- Sabby Management reported no remaining Ocera Therapeutics position as of Q1 2017 after selling out during the quarter.
- Sabby Management sold 328,632 Ocera Therapeutics shares in Q1 2017, an estimated $690K.
- Sabby Management first reported a position in Ocera Therapeutics in Q4 2013 and held it in 12 quarters.
- Sabby Management's Ocera Therapeutics position peaked at $2.74M in Q4 2014.
- 26 funds tracked by Wall St. Rank held Ocera Therapeutics as of Q1 2017.
Based on Sabby Management's 13F filing for Q1 2017, filed 15 May 2017.